ArticleAIDS (London, England)2026

Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort.

Luis Buzón-Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.